Spots Global Cancer Trial Database for Soft Coagulation for the Prevention of Adenoma Recurrence
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Soft Coagulation for the Prevention of Adenoma Recurrence
Official Title: Soft Coagulation for the Prevention of Adenoma Recurrence After Endoscopic Mucosal Resection (EMR) of Large Sessile Colonic Polyps: A Multicentre, Randomized Trial.
Study ID: NCT01789749
Conditions
Study Description
Brief Summary: Recurrence after endoscopic mucosal resection of laterally spreading lesions (LSL) \>= 20mm in size occurs in approximately 20% of cases at surveillance colonoscopy. We aim to evaluate the efficacy of prophylactic adjuvant thermal ablation of the EMR mucosal defect margin in reducing adenoma recurrence following colonic EMR.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Westmead Endoscopy Unit, Westmead, New South Wales, Australia
Princess Alexandra Hospital, Brisbane, Queensland, Australia
Lyell McEwin Hospital, Adelaide, South Australia, Australia
The Alfred Hospital, Melbourne, VA, Australia
Contact Details
Name: Michael Bourke, FRACP, MBBS
Affiliation: Western SLHD
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
